The glioblastoma multiforme (GBM) treatment market size is on a steep growth trajectory, rising from $2.73 billion in 2025 to ...

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

In 2025, the market was valued at $2.7 billion, projected to reach $2.92 billion in 2026, with a CAGR of 8.1%. This ...

Growing progress in vaccination: New approaches for the treatment of glioblastoma have recently been made possible by the quick advancements in immunotherapy. The injection of foreign antigens and ...

According to Market.us, the Glioblastoma Multiforme Treatment Market Size is expected to reach around USD 4.7 billion by 2033, indicating significant expansion compared to its valuation of USD 2.2 ...

A new CAR-T cell therapy has shown promising early results against glioblastoma, a highly aggressive brain cancer. In a phase ...

Chicago, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The global glioblastoma multiforme treatment market was valued at 3.0 billion in 2024 and is expected to reach US$ 6.1 billion by 2033, growing at a CAGR of ...

The Glioblastoma Multiforme (GBM) Treatment Market is projected to experience substantial growth from a 2023 valuation of USD 2.2 billion to approximately USD 4.7 billion by 2033, demonstrating a ...

Every year on July 16, Glioblastoma Awareness Day is observed to raise awareness about glioblastoma, the most common and aggressive type of malignant brain tumour in adults. This annual event aims to ...